Literature DB >> 13610669

Treatment of melanoma by isolation-perfusion technique.

O CREECH, R F RYAN, E T KREMENTZ.   

Abstract

Entities:  

Keywords:  LEG/neoplasms; MELANOMA/therapy; NITROGEN MUSTARDS/therapeutic use; PHENYLALANINE/related compounds

Mesh:

Substances:

Year:  1959        PMID: 13610669     DOI: 10.1001/jama.1959.03000210033008

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  14 in total

1.  Studies in isolated perfusion chemotherapy. I. Nitrogen mustard.

Authors:  R K AUSMAN; J B AUST
Journal:  Ann Surg       Date:  1961-04       Impact factor: 12.969

2.  MALIGNANT MELANOMA.

Authors:  L DOBSON
Journal:  Calif Med       Date:  1964-01

3.  Closed-circuit perfusion of liver utilizing an extracorporeal circulation.

Authors:  A ELEY
Journal:  Br Med J       Date:  1961-09-23

4.  An appraisal of cancer chemotherapy by regional perfusion.

Authors:  E T KREMENTZ; O CREECH; R F RYAN; K REEMTSMA
Journal:  Ann Surg       Date:  1962-09       Impact factor: 12.969

5.  Isolated Regional Perfusion in Treatment of Malignant Disease.

Authors:  O Garai; C Cooling; D Staunton
Journal:  Br Med J       Date:  1962-05-05

6.  Isolated regional perfusion in malignant melanoma of the extremities.

Authors:  H Schraffordt Koops; J Oldhoff; J W Oosterhuis; H Beekhuis
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

7.  Malignant melanomata of the nasal cavity.

Authors:  D F Harrison
Journal:  Proc R Soc Med       Date:  1968-01

8.  Effect of intra-arterial nitrogen mustard infusion on wound healing in rabbits. Formation of granulation tissue and wound contraction.

Authors:  J F Newcombe
Journal:  Ann Surg       Date:  1966-03       Impact factor: 12.969

9.  Regional isolation perfusion in the treatment of advanced malignant disease.

Authors:  H R TOLLETH; J D COLT
Journal:  Calif Med       Date:  1961-03

10.  Functional morbidity of hyperthermic isolated regional perfusion of the extremities.

Authors:  A F Olieman; H Schraffordt Koops; J H Geertzen; H Kingma; H J Hoekstra; J Oldhoff
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.